论文部分内容阅读
目的分析沙丁胺醇联合普米克令舒对哮喘急性发作患儿临床症状的改善作用。方法选取2013年4月—2015年1月于我院进行治疗的哮喘急性发作患儿110例,以随机数字表法分为观察组及对照组各55例。2组患儿均给予沙丁胺醇治疗,观察组在此基础上加用普米克令舒治疗,对比2组临床症状改善情况。结果观察组气促缓解时间和咳嗽消退时间分别为(2.42±1.04)d、(6.29±1.16)d,均显著短于对照组的(3.67±1.05)d、(8.24±1.27)d;观察组呼吸困难消失时间和哮鸣音消失时间分别为(2.01±0.53)d、(3.67±1.08)d,均显著短于对照组的(2.45±0.66)d、(4.36±1.39)d,差异有统计学意义(P<0.05)。结论沙丁胺醇联合普米克令舒对哮喘急性发作患儿临床症状有明显的改善作用,且安全性高,值得推广应用。
Objective To analyze the effect of salbutamol and pulmicort on the improvement of clinical symptoms in children with acute asthma. Methods A total of 110 children with acute asthma exacerbation who were treated in our hospital from April 2013 to January 2015 were randomly divided into observation group (55 cases) and control group (55 cases). Both groups were given albuterol treatment, the observation group was treated with Pulmicort resveratrol, and the clinical symptoms of the two groups were compared. Results The duration of relief and cough subsided in the observation group were (2.42 ± 1.04) d and (6.29 ± 1.16) days, respectively, which were significantly shorter than those in the control group (3.67 ± 1.05 and 8.24 ± 1.27 days, respectively) (2.01 ± 0.53) d and (3.67 ± 1.08) d respectively, which were significantly shorter than those in control group (2.45 ± 0.66) d and (4.36 ± 1.39) d respectively, with statistical difference Significance (P <0.05). Conclusions Salbutamol combined with pulmicort suppresses the clinical symptoms in children with acute asthma. It has high safety and is worth popularizing.